Categories: Research

Breast cancer patients might not be getting full advantage from a genetic screening test for the protein known as HER2 to help determine if the use of trastuzumab (marketed as Herceptin) is the best course of treatment for them. For patients whose breast cancer cells produce excessive amounts of...

Scientists from the UCSF School of Pharmacy's Department of Pharmaceutical Chemistry have been selected to lead a new federal initiative aimed at developing new classes of drugs to target cancer.

UCSF School of Pharmacy researchers and colleagues have successfully created a mathematical model that genetically programs bacteria and causes the bacteria to "trace" images projected onto them in a petri dish. The bacteria sense and display the area of the projection where light meets dark by...

UCSF School of Pharmacy researcher Lisa Bero, PhD, served with UCSF School of Medicine colleagues Bernard Lo, MD, and Deborah Grady,

UCSF researchers have identified the two key circuits, compared to hundreds as previously thought, that control a cell's ability to adapt to changes in its environment. These circuits are key to a cell's ability to reset itself after responding to a stimulus.

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Synthetic biologist and UCSF School of Pharmacy faculty member Christopher Voigt, PhD, and Jeffrey Tabor, a postdoctoral scholar in Voigt's laboratory, discuss the field and promise of synthetic biology in this July 21, 2009 KQED television segment.

Desai, a bioengineer who focuses on the design, fabrication, and use of advanced micro/nano biosystems, was chosen as a 2009 Emerging Scholar in Physiology by Diverse Issues in Higher Education.

Dorie Apollonio, PhD, UCSF School of Pharmacy faculty member and political science and health policy expert, received, with co-authors, the inaugural Best Article prize for 2007-2008 from the journal Regulation & Governance.

UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.